Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Chao Zheng

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Drug Targets|September 21, 2020
Epigenetic Modifications as Therapeutic TargetsYi-Chao Zheng, Si-Qi Feng
Current Drug Metabolism|January 7, 2020
Role of Drug-metabolizing Enzymes in Cancer and Cancer TherapySiqi Feng, Anqi Li, Yi-Chao Zheng, et al.
Frontiers in Pharmacology|August 25, 2022
Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancerZhi Shi, Ning Wang, Ying-Jie Zhang, et al.
Current Pharmaceutical Design|July 19, 2016
Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer TherapyYi-Chao Zheng, Jin-Lian Ma, Ying Liu, et al.
Bioorganic Chemistry|July 3, 2021
The design, synthesis and cellular imaging of a tumor-anchored, potent and cell-permeable BRD4-targeted fluorescent ligandsHang Zhang, Mingliang Zhang, Yi-Chao Zheng, et al.
Epigenomics|April 23, 2016
TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapyYi-Chao Zheng, Bin Yu, Zhe-Sheng Chen, et al.
Cancers|August 28, 2025
Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer TherapeuticsSeohyun Park, Guo-Liang Lu, Yi-Chao Zheng, et al.
Recent Patents on Anti-Cancer Drug Discovery|July 29, 2021
An Update of Lysine Specific Demethylase 1 Inhibitor: A Patent Review (2016-2020)Yi-Chao Zheng, Yue-Jiao Liu, Ya Gao, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 3, 2015
Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer AgentsBin Yu, Yi-Chao Zheng, Xiao-Jing Shi, et al.
Medicinal Research Reviews|May 12, 2020
Skp2 in the ubiquitin-proteasome system: A comprehensive reviewMoges Dessale Asmamaw, Ying Liu, Yi-Chao Zheng, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Drug Targets|September 21, 2020
Epigenetic Modifications as Therapeutic TargetsYi-Chao Zheng, Si-Qi Feng
Current Drug Metabolism|January 7, 2020
Role of Drug-metabolizing Enzymes in Cancer and Cancer TherapySiqi Feng, Anqi Li, Yi-Chao Zheng, et al.
Frontiers in Pharmacology|August 25, 2022
Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancerZhi Shi, Ning Wang, Ying-Jie Zhang, et al.
Current Pharmaceutical Design|July 19, 2016
Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer TherapyYi-Chao Zheng, Jin-Lian Ma, Ying Liu, et al.
Bioorganic Chemistry|July 3, 2021
The design, synthesis and cellular imaging of a tumor-anchored, potent and cell-permeable BRD4-targeted fluorescent ligandsHang Zhang, Mingliang Zhang, Yi-Chao Zheng, et al.
Epigenomics|April 23, 2016
TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapyYi-Chao Zheng, Bin Yu, Zhe-Sheng Chen, et al.
Cancers|August 28, 2025
Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer TherapeuticsSeohyun Park, Guo-Liang Lu, Yi-Chao Zheng, et al.
Recent Patents on Anti-Cancer Drug Discovery|July 29, 2021
An Update of Lysine Specific Demethylase 1 Inhibitor: A Patent Review (2016-2020)Yi-Chao Zheng, Yue-Jiao Liu, Ya Gao, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 3, 2015
Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer AgentsBin Yu, Yi-Chao Zheng, Xiao-Jing Shi, et al.
Medicinal Research Reviews|May 12, 2020
Skp2 in the ubiquitin-proteasome system: A comprehensive reviewMoges Dessale Asmamaw, Ying Liu, Yi-Chao Zheng, et al.
Pageof 8